Nicholas N. Nissen

4.8k total citations · 1 hit paper
128 papers, 3.2k citations indexed

About

Nicholas N. Nissen is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Nicholas N. Nissen has authored 128 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 60 papers in Surgery and 43 papers in Epidemiology. Recurrent topics in Nicholas N. Nissen's work include Pancreatic and Hepatic Oncology Research (48 papers), Neuroendocrine Tumor Research Advances (24 papers) and Liver Disease and Transplantation (19 papers). Nicholas N. Nissen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (48 papers), Neuroendocrine Tumor Research Advances (24 papers) and Liver Disease and Transplantation (19 papers). Nicholas N. Nissen collaborates with scholars based in United States, China and Italy. Nicholas N. Nissen's co-authors include Run Yu, Deepti Dhall, Luisa A. DiPietro, Richard L. Gamelli, Andrew Hendifar, Shelly C. Lu, Mazen Noureddin, Peter J. Polverini, Steven D. Colquhoun and Tram T. Tran and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nicholas N. Nissen

123 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

2018 439 citations Mazen Noureddin, Catherine Bresee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas N. Nissen United States	31	1.4k	1.0k	977	904	497	128	3.2k
Joseph Misdraji United States	38	1.1k 0.8×	2.3k 2.2×	859 0.9×	577 0.6×	207 0.4×	133	4.2k
Christoph Roderburg Germany	23	903 0.7×	443 0.4×	707 0.7×	601 0.7×	760 1.5×	175	2.7k
Mariana Berho United States	34	1.9k 1.4×	1.9k 1.8×	1.3k 1.4×	1.5k 1.7×	338 0.7×	116	5.1k
Sara Massironi Italy	35	2.4k 1.8×	1.2k 1.2×	1.3k 1.3×	957 1.1×	313 0.6×	150	4.1k
J.I. Herrero Spain	34	1.6k 1.2×	1.4k 1.4×	539 0.6×	1.9k 2.1×	144 0.3×	130	3.4k
Arndt Weinmann Germany	32	1.1k 0.8×	691 0.7×	716 0.7×	1.7k 1.9×	602 1.2×	161	3.3k
Michele Masetti Italy	32	693 0.5×	2.0k 1.9×	732 0.7×	1.0k 1.1×	253 0.5×	132	3.2k
A. Aupérin France	29	602 0.4×	839 0.8×	1.2k 1.2×	456 0.5×	330 0.7×	77	3.2k
Mehdi Mohamadnejad Iran	29	1.1k 0.8×	1.3k 1.3×	507 0.5×	1.1k 1.3×	469 0.9×	88	3.1k
J. Klempnauer Germany	31	845 0.6×	1.4k 1.4×	452 0.5×	1.2k 1.3×	419 0.8×	144	3.4k

Countries citing papers authored by Nicholas N. Nissen

Since Specialization

Citations

This map shows the geographic impact of Nicholas N. Nissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas N. Nissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas N. Nissen more than expected).

Fields of papers citing papers by Nicholas N. Nissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas N. Nissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas N. Nissen. The network helps show where Nicholas N. Nissen may publish in the future.

Co-authorship network of co-authors of Nicholas N. Nissen

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas N. Nissen. A scholar is included among the top collaborators of Nicholas N. Nissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas N. Nissen. Nicholas N. Nissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gangi, Alexandra, Motaz Qadan, Andrew Hendifar, et al.. (2025). Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors. JAMA Surgery. 161(2). 142–142.

Wisel, Steven A., et al.. (2024). Implications of drug intoxication on donor utilization and outcomes in liver transplantation. Clinical Transplantation. 38(3). e15276–e15276. 1 indexed citations

Lu, Diana J., Anthony T. Nguyen, Andrew Hendifar, et al.. (2024). Patterns of Failure in Patients With Borderline Resectable/Locally Advanced Pancreatic Cancer After Preoperative Chemotherapy and Stereotactic Body Radiation Therapy. Advances in Radiation Oncology. 9(5). 101471–101471. 2 indexed citations

Shishido, Stephanie N., Nicholas N. Nissen, Jeremy Mason, et al.. (2024). Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery. npj Precision Oncology. 8(1). 36–36. 10 indexed citations

Wisel, Steven A., Noriko Ammerman, Ashley Vo, et al.. (2023). Successful treatment of acute antibody-mediated rejection of liver allograft with imlifidase: A case report. SHILAP Revista de lepidopterología. 8(3). 100145–100145. 3 indexed citations

Tuli, Richard, Fergus Keane, Joshua D. Schoenfeld, et al.. (2023). A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer.. Journal of Clinical Oncology. 41(16_suppl). 4164–4164. 1 indexed citations

Rosenzweig, Allison, Jordan Berlin, Suresh T. Chari, et al.. (2023). Management of Patients With Pancreatic Cancer Using the “Right Track” Model. The Oncologist. 28(7). 584–595. 10 indexed citations

Ramani, Komal, Aaron Robinson, Wei Fan, et al.. (2021). S‐adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells. Hepatology. 75(2). 280–296. 22 indexed citations

Placencio-Hickok, Veronica, Marie Lauzon, Michelle Guan, et al.. (2021). Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. Pancreatology. 22(1). 92–97. 9 indexed citations

10.

Podboy, Alexander, Nicholas N. Nissen, & Simon K. Lo. (2021). Single-session EUS-directed transgastric endoscopic retrograde cholangiopancreatography (EDGE) and EUS-guided gallbladder drainage is safe and feasible. VideoGIE. 6(11). 509–511. 4 indexed citations

11.

Lee, Yi‐Te, Jasmine J. Wang, Michael Luu, et al.. (2021). State‐Level HCC Incidence and Association With Obesity and Physical Activity in the United States. Hepatology. 74(3). 1384–1394. 27 indexed citations

12.

Osipov, Arsen, Benedick A. Fraass, Howard M. Sandler, et al.. (2017). Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. Journal of Gastrointestinal Oncology. 8(1). 127–138. 58 indexed citations

13.

Zhu, Li, Laura H. Tang, Xinwei Qiao, et al.. (2016). Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States. Medicine. 95(7). e2836–e2836. 49 indexed citations

14.

Yu, Run, et al.. (2016). A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series. Pancreas. 46(1). 48–56. 19 indexed citations

15.

Nissen, Nicholas N., Vijay G. Menon, James A. Williams, & George Berci. (2011). Video-microscopy for use in microsurgical aspects of complex hepatobiliary and pancreatic surgery: a preliminary report. HPB. 13(10). 753–756. 3 indexed citations

16.

Nissen, Nicholas N., Vijay G. Menon, Catherine Bresee, et al.. (2011). Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient. HPB. 13(9). 626–632. 19 indexed citations

17.

Nawabi, Atta, Nicholas N. Nissen, Charles Forscher, et al.. (2009). Primary Hepatic Osteosarcoma. Journal of Gastrointestinal Surgery. 13(8). 1550–1553. 7 indexed citations

18.

Nissen, Nicholas N. & Andrew S. Klein. (2008). Choledocho-Choledochostomy in Deceased Donor Liver Transplantation. Journal of Gastrointestinal Surgery. 13(4). 810–813. 3 indexed citations

19.

Kleisli, Thomas, Sharo Raissi, Nicholas N. Nissen, et al.. (2006). Cavo-Atrial Tumor Resection Under Total Circulatory Arrest Without a Sternotomy. The Annals of Thoracic Surgery. 81(5). 1887–1888. 3 indexed citations

20.

Nissen, Nicholas N., Ravi Shankar, Richard L. Gamelli, Ashok K. Singh, & Luisa A. DiPietro. (1999). Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochemical Journal. 338(3). 637–642. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact